Breaking News
LAST CHANCE for Cyber Monday SALE: Up to 54% off InvestingPro! Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Puma Biotechnology Inc (PBYI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Puma Biotech's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.225 -0.255    -7.33%
26/11 - Closed. Currency in USD ( Disclaimer )
After Hours
3.225
0.000
0.000%
16:20:00 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US74587V1070 
CUSIP:  74587V107
  • Volume: 538,825
  • Bid/Ask: 3.180 / 3.280
  • Day's Range: 3.130 - 3.660
Puma Biotech 3.225 -0.255 -7.33%
RankUsernameTotalClosedWinningWin %Chg. %
1Robbert Kuipers111100+318.59%
2Reuben Johnson111100+315.91%
3Lukas Hajek211100+307.13%
4Simon Lee111100+297.85%
5Christopher Muñoz111100+294.63%
6Jimi Garnier111100+288.34%
7Magdy Samy111100+286.79%
8Mahmoud Sarhan33133.33+282.73%
9maris ozols111100+258.33%
10גבע הוכמן22150+248.93%
11Ignazio Mosca111100+237.08%
12Kubanychbek Asylbekov111100+236.36%
13Martin Petersen111100+208.51%
14Episcopolian1111100+100%
15Josema Campos111100+82.22%
16Pavel Ilin111100+80.7%
17arie Sklar111100+69.72%
18Lee Ai222100+47.9%
19Bala Pala21211571.43+41.35%
20Celso Filipe Martins111100+39.49%
21davide garulli22150+29.48%
22ramon ramirez111100+29.42%
23Vasko Kotsev111100+29.24%
24Сергей Воробьев111100+28.24%
25Eniel Gonzalez55240+27.75%
26Federico Rodenas111100+22.74%
27Anthony Santos111100+18.81%
28Mario Alberto Bertocchi111100+18.45%
29Miguel Clos Uribe111100+17.46%
30일환 이111100+16.97%
31Sunil Anand111100+16.44%
32Yeoshua Syrquin111100+15.88%
33Валерий Гусев22150+12.99%
34Claudinho Rodrigues111100+12.65%
35thekeystonegamer thorpe111100+12.32%
36Awais Anwar111100+11%
37Bun Ly111100+10.07%
38danil_H111100+8.99%
39Eden Izhak Hemo111100+8.42%
40Asif Mohamed111100+7.17%
41Семен Чайковский111100+6.05%
42Aleksi Jurvanen211100+4.83%
43Nicola Bracale32150+4.75%
44Robbert Kuipers111100+4.55%
45Michael ROUX111100+4.3%
46Szymon Formela111100+4.29%
47Elio Giudice111100+3.83%
48chelsea wang111100+3.5%
49Bert Rogmans111100+3.31%
50Itamar Haim111100+1.2%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PBYI Comments

Write your thoughts about Puma Biotechnology Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jimmy Barjami
Jimmy Barjami Nov 17, 2021 7:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What’s going on with this toxic stock
Episcopolian OptionTrader
Episcopolian1 May 07, 2020 4:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Puma Biotechnology Q1 Adj. EPS $(0.200) Beats $(0.730) Estimate, Sales $48.600M Beat $47.060M Estimate
Peter Wiedeking
Peter Wiedeking Feb 05, 2020 1:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
14,5 short
Anthony Santos
Anthony Santos Nov 06, 2019 9:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
today will be earnings as All eyes will be on the Useless CEO
Episcopolian OptionTrader
Episcopolian1 Jul 12, 2017 10:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Leerink set PT to $115. Wonder if they think there is no immediate buyer?
Episcopolian OptionTrader
Episcopolian1 May 23, 2017 8:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$PBYI will be presenting at ASCO on 6/3/17. Buy the stock now... This can go above $100 easily before the event
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email